Hikma Pharmaceutical | HIK - Cost Of Sales

Stock Price
1,314.00
Daily Change
-59.00 -4.30%
Monthly
-14.29%
Yearly
-39.17%
Q1 Forecast
1,600.34

Hikma Pharmaceutical reported $466.5M in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Almirall EUR 191.5M 2.29M Dec/2025
argenx SE USD 149.69M 40.26M Dec/2025
AstraZeneca USD 3.27B 471M Dec/2025
Autolus Therapeutics Ltd USD 24.91M 6.96M Jun/2025
Bayer EUR 4.31B 57M Sep/2025
Fresenius EUR 4.45B 262M Dec/2025
Galapagos EUR 84.73M 80.02M Sep/2025
Genmab DKK 57M 15M Jun/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.13B 15.63M Sep/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.1B 123M Sep/2025
Orion EUR 186.6M 17.6M Dec/2025
Recordati EUR 199.91M 20.12M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
UCB EUR 901M 50M Dec/2024